# Methodology Comparison Report - Test ID: ahhcuJnMV1

**Comparison of Statistical Methods**: Difference-in-Differences vs CUPED vs Regular Analysis

---

## SECTION 1 – Executive Summary

### Key Findings at a Glance

| Methodology | Treatment Effect | 95% Confidence Interval | Statistical Significance | CI Width |
|-------------|------------------|-------------------------|-------------------------|----------|
| **Difference-in-Differences** | -1.57% (-$0.0199) | [-5.36%, +2.22%] | Not Significant | 7.58% |
| **CUPED (Pure)** | -0.78% (-$0.0105) | [-4.26%, +2.70%] | Not Significant | 6.96% |
| **Regular (Direct Comparison)** | +2.70% (+$0.0355) | [-3.14%, +8.54%] | Not Significant | 11.68% |

### Executive Summary

**CUPED demonstrates superior precision** with the narrowest confidence interval (6.96% width vs 7.58% for Diff-in-Diff and 11.68% for Regular), representing a **64.6% variance reduction** compared to direct analysis. However, **methodological differences lead to contradictory conclusions**: Diff-in-Diff and CUPED suggest negative treatment effects while Regular analysis suggests a positive effect. 

**Statistical Power**: CUPED provides the most precise estimates, making it the most sensitive method for detecting treatment effects. None of the methods achieve statistical significance, but CUPED comes closest to reliable inference.

**Business Implication**: The divergent results highlight the importance of choosing appropriate analytical methodology, as the business conclusion varies dramatically across methods.

---

## SECTION 2 – Methodology Overview

### Difference-in-Differences (Diff-in-Diff)

**Purpose**: Estimates treatment effects by comparing changes over time between treatment and control groups, effectively removing common time trends and external factors.

**Calculation Flow**:

**Per User**:
```
user_diff = avg_rev_during - avg_rev_before
```

**Per Group**:
```
mean_user_diff = AVG(user_diff)
variance_user_diff = VARIANCE(user_diff)  
n_users = COUNT(*)
```

**Treatment Effect**:
```
Effect = mean_user_diff_test - mean_user_diff_control

Equivalent to:
(Test_During - Test_Before) - (Control_During - Control_Before)
```

**Statistical Inference**:
```
Standard Error = SQRT(var_test/n_test + var_control/n_control)
95% CI = Effect ± 1.96 × SE
```

**What Diff-in-Diff Answers**: "What is the causal effect of treatment after removing time trends that affected both groups equally?"

**Why User-Level Change Scores**: By analyzing individual change patterns, Diff-in-Diff controls for unobserved heterogeneity and removes time-invariant confounders.

**Key Assumptions**: 
- **Parallel Trends**: Without treatment, both groups would experience similar changes
- **No Spillover Effects**: Treatment doesn't affect the control group
- **Stable Treatment**: Effect is consistent across the experiment period

---

### CUPED (Controlled-experiment Using Pre-Experiment Data)

**Purpose**: Reduces variance in randomized experiments by using pre-period data as a control variate, improving statistical precision without bias.

**Calculation Flow**:

**Covariance and Variance**:
```
X = avg_rev_before (pre-period metric)
Y = avg_rev_during (outcome metric)

Theta = COV(Y,X) / VAR(X)
```

**CUPED Adjustment**:
```
Y_CUPED = Y - theta × (X - mean(X))
```

**Per Group**:
```
mean_Y_CUPED = AVG(Y_CUPED)
variance_Y_CUPED = VARIANCE(Y_CUPED)
n_users = COUNT(*)
```

**Treatment Effect**:
```
Effect = mean_Y_CUPED_test - mean_Y_CUPED_control
```

**Statistical Inference**:
```
Standard Error = SQRT(var_test/n_test + var_control/n_control)
95% CI = Effect ± 1.96 × SE
```

**What CUPED Answers**: "What is the treatment effect after optimally adjusting for pre-period behavior to minimize variance?"

**How Pre-Period Incorporation**: Uses the correlation between pre and during periods to create a variance-reduced version of the outcome metric while maintaining unbiased estimates.

**Why Variance Reduction Expected**: Strong correlation between before/during periods (r=0.78 in this case) allows CUPED to remove predictable variation, leaving only treatment-related and truly random variation.

---

### Regular Analysis (Direct Comparison)

**Purpose**: Provides baseline comparison by directly comparing outcome metrics between groups without any adjustment.

**Calculation Flow**:
```
Treatment Effect = AVG(Y_during_test) - AVG(Y_during_control)
Standard Error = SQRT(var_during_test/n_test + var_during_control/n_control)  
95% CI = Effect ± 1.96 × SE
```

**What Regular Analysis Answers**: "What is the raw difference in outcome metrics between treatment groups?"

---

## SECTION 3 – Statistical Results Comparison

### Comprehensive Results Table

| Method | Treatment Effect ($) | Treatment Effect (%) | CI Lower (%) | CI Upper (%) | CI Width (%) | Standard Error | Significant? |
|--------|---------------------|---------------------|--------------|--------------|--------------|----------------|--------------|
| **Diff-in-Diff** | -$0.0199 | -1.57% | -5.36% | +2.22% | 7.58% | $0.0244 | No |
| **CUPED (Pure)** | -$0.0105 | -0.78% | -4.26% | +2.70% | 6.96% | $0.0240 | No |
| **Regular** | +$0.0355 | +2.70% | -3.14% | +8.54% | 11.68% | $0.0297 | No |

### Effect Direction Analysis

| Method | Direction | Magnitude | Interpretation |
|--------|-----------|-----------|----------------|
| **Diff-in-Diff** | Negative | Moderate (-1.57%) | Treatment reduces revenue growth rate |
| **CUPED** | Negative | Small (-0.78%) | Treatment slightly reduces variance-adjusted revenue |
| **Regular** | Positive | Moderate (+2.70%) | Treatment increases absolute revenue levels |

### Sample Size and Population

**Consistent Across All Methods**:
- **Test Group**: 447,513 users
- **Control Group**: 111,917 users  
- **Total Population**: 559,430 "during users" (active in experiment period)
- **Time Periods**: 14-day pre-period, 7-day experiment period

---

## SECTION 4 – Variance Reduction Analysis

### Variance Comparison

| Method | Outcome Variance | Standard Error | Variance vs Regular | Variance Reduction |
|--------|------------------|----------------|-------------------|-------------------|
| **Diff-in-Diff** | user_diff variance* | $0.0244 | -17.5% higher SE | N/A (different metric) |
| **CUPED** | 56.83 (pooled Y_CUPED) | $0.0240 | -19.2% lower SE | **64.6% reduction** |
| **Regular** | 160.44 (during period) | $0.0297 | Baseline | 0% (reference) |

*Note: Diff-in-Diff uses variance of change scores, not directly comparable to level variances

### CUPED Variance Reduction Calculation

```
CUPED Variance Reduction = (1 - CUPED_variance / Regular_variance) × 100
                        = (1 - 56.83 / 160.44) × 100  
                        = 64.6% reduction
```

### Statistical Power Assessment

**Most Precise → Least Precise**:
1. **CUPED** (SE = $0.0240): Smallest confidence interval width
2. **Diff-in-Diff** (SE = $0.0244): Similar precision to CUPED  
3. **Regular** (SE = $0.0297): Widest confidence intervals

**CUPED Success Factors**:
- **Strong Pre-During Correlation** (r = 0.78): Excellent variance reduction potential
- **Optimal Theta Coefficient** (θ = 0.8302): Effective covariance weighting
- **Pure Implementation**: No reintroduction of pre-period bias

---

## SECTION 5 – Interpretation

### Statistical Consistency Analysis

**Direction Agreement**: 
- ❌ **Major Discrepancy**: Diff-in-Diff (-1.57%) and CUPED (-0.78%) suggest negative effects, while Regular (+2.70%) suggests positive effects
- ❌ **Magnitude Variation**: Effects range from -1.57% to +2.70%, a 4.27 percentage point spread

**Effect Size Assessment**:
- **Small to Moderate Effects**: All estimates are <3%, within typical experimental noise
- **Overlapping Confidence Intervals**: All methods include zero, indicating uncertainty
- **No Statistical Significance**: None achieve p < 0.05 threshold

### Method-Specific Insights

**Diff-in-Diff Interpretation**:
- Controls for time trends affecting both groups
- Suggests treatment dampened natural revenue growth
- Based on user-level change patterns

**CUPED Interpretation**:  
- Provides variance-reduced estimates using pre-period correlation
- Shows smaller negative effect after controlling for baseline behavior
- Most precise methodology statistically

**Regular Interpretation**:
- Shows raw group differences without adjustment
- Positive effect may reflect selection or time trend differences
- Highest variance, least reliable for causal inference

### Reliability Assessment

**Most Reliable → Least Reliable**:
1. **CUPED**: Best variance reduction, proper randomized experiment analysis
2. **Diff-in-Diff**: Good causal inference properties, controls for time trends
3. **Regular**: No adjustment for confounders, highest variance

### Methodological Explanations for Differences

**Why CUPED vs Regular Differ**:
- CUPED removes variation correlated with pre-period behavior
- Regular analysis includes all baseline heterogeneity
- Pre-period adjustment can reveal different underlying patterns

**Why Diff-in-Diff vs Others Differ**:
- Diff-in-Diff focuses on change scores rather than levels
- Explicitly models time trends rather than assuming they're absent
- Different assumptions about what constitutes the "treatment effect"

---

## SECTION 6 – Recommendation

### Primary Recommendation: **CUPED**

**For Future Experiment Analysis**, CUPED should be the **preferred methodology** based on:

1. **Superior Statistical Power**: 64.6% variance reduction provides most precise estimates
2. **Narrowest Confidence Intervals**: 6.96% width vs 7.58% (Diff-in-Diff) and 11.68% (Regular)
3. **Established Best Practice**: Standard methodology for randomized experiments in tech industry
4. **Dashboard Alignment**: Matches production implementation methodology
5. **Unbiased Estimates**: Maintains experimental validity while improving precision

### Conditional Recommendations

**Use Diff-in-Diff When**:
- ✅ **Time trends are suspected**: External factors may differentially affect groups
- ✅ **Quasi-experimental design**: Non-randomized or observational data
- ✅ **Long experiment periods**: Time trends more likely over extended periods  
- ✅ **Regulatory/academic context**: Causal inference requirements prioritize trend control

**Use CUPED When**:
- ✅ **Proper randomization**: True randomized controlled experiment
- ✅ **Statistical power priority**: Need to detect smaller effect sizes
- ✅ **Strong pre-period correlation**: r > 0.5 for meaningful variance reduction
- ✅ **Production environment**: Consistent with existing dashboard methodology
- ✅ **Frequent experimentation**: Standard A/B testing workflow

**Avoid Regular Analysis When**:
- ❌ **Baseline differences exist**: Groups differ in pre-period behavior
- ❌ **High variance outcomes**: Revenue, engagement metrics with natural variation
- ❌ **Statistical power matters**: Need to detect realistic effect sizes

### Dashboard Alignment Assessment

**CUPED is closest to production dashboard implementation** because:
- Uses identical variance reduction principles
- Follows standard A/B testing methodology in experimentation platforms
- Provides confidence intervals matching dashboard calculations
- Maintains consistency with existing business processes

### Implementation Guidance

**For Test ID ahhcuJnMV1 Specifically**:
- **Business Decision**: No significant treatment effect detected by any method
- **Recommended Action**: Continue monitoring with CUPED methodology
- **Statistical Conclusion**: Insufficient evidence to conclude treatment impact
- **Confidence**: CUPED provides most reliable estimate (±2.70% range vs ±8.54% for Regular)

**For Future Experiments**:
- **Primary Analysis**: Use CUPED for all randomized A/B tests  
- **Secondary Analysis**: Include Diff-in-Diff when time trends are suspected
- **Sensitivity Analysis**: Compare multiple methods when results are borderline significant
- **Documentation**: Report variance reduction achieved to validate CUPED effectiveness

### Quality Assurance Recommendations

1. **Pre-Experiment**: Verify strong correlation (r > 0.5) between pre-period and outcome metrics
2. **During Experiment**: Monitor for external events that might create time trends
3. **Post-Experiment**: Calculate variance reduction percentage to confirm CUPED benefit
4. **Cross-Validation**: Use Diff-in-Diff as robustness check for CUPED results
5. **Business Translation**: Report both statistical significance and practical significance thresholds